THE STORY IN BRIEF
  • WHO marked African Traditional Medicine Day on 31 August with a discussion on research and access.
  • South Africa’s national commemoration was scheduled in Mpumalanga.
  • WHO’s strategy calls for evidence, safety and regulation alongside work on integration.
MAKE TIME FOR A GOOD READ
Inside this story 2 perspectives

A health consultation often begins with a question about medicines. The answer can depend on what the person asking means by the word. A patient may think of tablets from a clinic and leave out a preparation supplied by a traditional health practitioner. A clinician who asks only about prescriptions might never discover the gap. Both can leave feeling they have had a complete conversation while holding different versions of the patient’s history.

African Traditional Medicine Day, marked on 31 August, brings that ordinary exchange into a much larger discussion. The World Health Organization used the day to examine research, access and the place of traditional practitioners in efforts to extend health coverage. South Africa’s Department of Health scheduled its national commemoration in Mpumalanga, with traditional practitioners, health officials and the WHO country representative among the expected participants.

The kinds of evidence people bring

A practitioner may know which people in a community seek help, what they call a particular problem and why they struggle to reach a clinic. That is valuable knowledge about access and experience. A researcher evaluating a particular preparation is asking another set of questions. What precisely was used? For which condition? How were outcomes measured, what other care did people receive and what unwanted effects occurred?

The WHO strategy for 2025 to 2034 includes strengthening evidence, improving safety and regulation, and integrating appropriate practices within health systems. The order in which questions are posed matters. A long history of use can help researchers decide what to study. It cannot, by itself, establish the benefits or risks of a particular product for a particular person. Equally, a study that ignores the circumstances in which people seek care may do little to improve access in their community.

A conversation in both directions

WHO’s discussion included representatives of traditional leadership and research in Nigeria and a Kenyan moderator. It drew attention to communities where a traditional practitioner may be the first person someone sees. From a patient’s perspective, cooperation becomes concrete when that first conversation makes the next one easier. Can the person describe what has already happened without embarrassment? Is it clear who can assess a new symptom or answer a question about a medicine?

Being able to name a preparation, explain how it was used or bring its packaging can give the next practitioner more information. A clinician who asks in plain language and listens without ridicule creates room for a more accurate account. Where the identity of a product or its effects are uncertain, that uncertainty belongs in the conversation as well.

The commemoration does not settle questions about any individual treatment. Its practical importance lies in getting the right people into conversations that patients already navigate for themselves. A complete care history begins with a question broad enough to receive an honest answer.

BB
ABOUT THE AUTHOR

Beyond Business Editors

Editorial desk

Beyond Business connects global developments with the decisions, ambitions and everyday lives of its readers. Our editorial desk explores the stories shaping our world.

More from this author
Keep the perspective.